Lee Rubin, Principal Investigator and Director of Translational Medicine at Harvard Stem Cell Institute, presented at last year’s Stem Cells USA & Regenerative Medicine Congress on the topic, ‘Using stem cell-based..
Kristin Comella, Chief Scientific Officer at Bioheart Inc, presented at last year’s Stem Cells USA & Regenerative Medicine Congress on the topic, ‘Conducting the first trial of its kind and overcoming the challenges..
Natalie Mount, Executive Director, Development Lead at Pfizer Regenerative Medicine, presented at last year’s Stem Cells USA & Regenerative..
Yael Margolin, President & CEO of Gamida Cell Ltd., provided this overview of StemEx®. Gamida Cell is currently seeking a strategic partner..
In the first quarter of 2012, publicly traded companies in the cell-based therapy industry continued to show promising overall growth. Highlights..
On Tuesday 22nd May our very own Stem Cells course trainer, Erik Miljan, will be presenting a webinar on 3D culture in drug discovery and..
The Scientist recently reported that the legality of federally funding human embryonic stem cell (hESC) research is being questioned in court..
FierceBiotech recently reported that Shire is buying the biotech Pervasis Therapeutics with an eye toward boosting its regenerative medicine..
The Stem Cells USA & Regenerative Medicine Congress is back for its 4th consecutive year. As North America’s leading commercially-focused..
Experimental stem cells surgery repairs human heart Read the original article here Months ago, a procedure was led by a Yale..
Fiercebiotech recently reported that: Stem cell research is making significant strides so far this year, advancing in often-unexpected directions...
